A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype

Giulia Iapadre, Giovanni Morana, Maria Stella Vari, Francesca Pinto, Paola Lanteri, Alessandra Tessa, Filippo Maria Santorelli, Pasquale Striano, Alberto Verrotti

Research output: Contribution to journalArticlepeer-review


Background: Charcot-Marie-Tooth (CMT) neuropathies represent the most common forms of inherited polyneuropathies. CMT2A, the axonal form, accounts for about one third of all CMT cases. Variants in the MFN2 gene have been recognized to be a major cause of CMT2A. To date, more than 100 pathogenetic mutations in MFN2 have been identified, leading to different neurological clinical spectrum, varying from hereditary neuropathies to more severe clinical phenotypes. Pathogenic variants in MFN2 mainly act in a dominant manner, although in a few sporadic or familial cases, homozygous or compound heterozygous mutations have been reported. Results: We describe a child carrying a novel homozygous MFN2 mutation leading to an early-onset sensorimotor axonal neuropathy with an atypical and severe phenotype. Conclusion: The case highlights a very rare mechanism of inheritance for MFN2 mutations and expands the clinical and allelic variance of severe CMT2A phenotype. Moreover, it proposes the involvement of cerebellar peduncles observed at neuroimaging as a novel clue to suspect the diagnosis and address genetic testing.

Original languageEnglish
JournalEuropean Journal of Paediatric Neurology
Publication statusAccepted/In press - Dec 28 2017


  • Charcot-Marie-Tooth
  • CMT2
  • Homozygous mutation
  • MFN2
  • Mitofusin 2
  • Neuropathy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology


Dive into the research topics of 'A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype'. Together they form a unique fingerprint.

Cite this